Drug class

Alkyl Sulfonates

Alkyl sulfonates are a subclass of bifunctional alkylating antineoplastic agents characterized by sulfonic acid ester groups. Read more about Alkyl Sulfonates

11 drugs in this class 11 manufacturers

Advertisement

Drugs in Alkyl Sulfonates

Showing 1–9 of 11 drugs

BUSULFEX (busulfan)

ALKYL SULFONATES · CONDITIONING PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
Otsuka Pharmaceutical Co., Ltd.

BUSULFAN

ALKYL SULFONATES · CONDITIONING PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
American Regent

BUSULFAN

ALKYL SULFONATES · CONDITIONING PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
SAGENT PHARMACE

BUSULFAN

ALKYL SULFONATES · CONDITIONING PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
MYLAN INSTITUTI

BUSULFAN

ALKYL SULFONATES · CONDITIONING PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
Hospira

BUSULFAN

ALKYL SULFONATES · CONDITIONING PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
ATHENEX PHARMAC

BUSULFAN

ALKYL SULFONATES · CONDITIONING PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
ACCORD HEALTHCA

BUSULFAN

ALKYL SULFONATES · CONDITIONING PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
ARMAS PHARMACEU

MYLERAN (busulfan)

ALKYL SULFONATES · CONDITIONING PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT ·+1
WAYLIS THERAPEU
Filter & compare in the drug finder → Opens the drug finder with Alkyl Sulfonates preselected. Add indication or manufacturer filters there.

About Alkyl Sulfonates.

Alkyl sulfonates are a subclass of bifunctional alkylating antineoplastic agents characterized by sulfonic acid ester groups.

These agents exert cytotoxicity by transferring alkyl groups to cellular nucleophiles, particularly forming covalent intra- and inter-strand cross-links with DNA that disrupt replication and transcription, ultimately triggering apoptosis in rapidly proliferating cells.

Because they exhibit pronounced selectivity for hematopoietic stem cells and early myeloid precursors, alkyl sulfonates—exemplified by busulfan—are primarily indicated in hematology and oncology.

Their major clinical applications include the management of chronic myeloid leukemia and high-dose conditioning regimens prior to allogeneic or autologous hematopoietic stem cell transplantation.